Till startsida
Till innehåll Läs mer om hur kakor används på gu.se

Publikationer 2003

Andersson H, Elgqvist J, Horvath G, Hultborn R, Jacobsson L, Jensen H, Karlsson B, Lindegren S and Palm S

Astatine-211-labeled Antibodies for Treatment of Disseminated Ovarian Cancer: An Overview of Results in an Ovarian Tumor Model.
Clinical Cancer Research, vol. 9, 3914s-3921s, september 1, 2003.

Bernhardt P, Benjegård SA, Nilsson O, Kölby L, Ahlman H and Forssell-Aronsson E

Biodistribution of 111In-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: influence of injected amount and administration route.
Nucl Med Biol, 30:253-260, 2003.

Bernhardt P, Ahlman H, Nilsson O, Benjegård SA and Forssell-Aronsson E

Evaluation of 111In labeled somatostatin analogs for targeted therapy of somatostatin receptor positive tumors.
Cancer Biotherapy and Radiopharmaceuticals 18(2): 249-252, 2003.

Bernhardt P, Ahlman H and Forssell-Aronsson E

Model of metastatic growth valuable for radionuclide therapy.
Med Phys 30:3227-3232, 2003.

Börjesson J, Isaksson M and Mattsson S

X-ray fluorescence analysis in medical sciences: a review
Acta Diabetol(2003) 40:S39-S44

Carlsson J, Forssell-Aronsson E, Hietala S-O, Stigbrand T and Tennvall J

Tumour therapy with radionuclides – assessment of progress and problems.
Radiother Oncol 66(2):107-117, 2003.

Fredlund K, Bergman E L, Rossander-Hulthén L, Isaksson M, Almgren A and Sandberg A-S

Hydrothermal treatment and malting of barley improved zinc absotption but not calcium absorption in humans.
European Journal of Clinical Nutrition (2003)57, 1507-113

Hashemi SH, Benjegård SA, Ahlman H, Wängberg B, Forssell-Aronsson E, Billig H and Nilsson O

Expression of sstr2 in neuroendocrine tumours studied by ribonuclease protection assay related to 111In-octreotide binding.
Br J Surg 90(5):549-554, 2003.

Isaksson M, Bosaeus I, Surac Y and Alpsten M

Determination of potassium in the skeletal muscles by whole-body counting.
Acta Diabetol (2003) 40:s68-s72

Johansson KA, Mattsson S, Brahme A, Carlsson J, Zackrisson B, Turesson I, and the Swedish Cancer Society Investigation Group (including Forssell-Aronsson E)

Radiation therapy dose delivery.
Acta Oncol 42: 85-91, 2003.

Kölby L, Bernhardt P, Levin-Jakobsen AM, Wängberg B, Ahlman H, Forssell-Aronsson E and Nilsson O

Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters.
Br J Cancer 89: 1383-1388, 2003.

Ljungberg M, Stibrant Sunnerhagen K, Vikhoff-Baaz B, Starck G, Forssell-Aronsson E, Hedberg M, Ekholm S and Grimby G

31P MRS evaluation of fatigue in anterior tibial muscle in postpoliomyelitis patients and healthy volunteers.
Clin Physiol Funct Imag, 23:190-198, 2003.

Schmitt A, Bernhardt P, Nilsson O, Ahlman H, Kölby L, Schmitt J and Forssell-Aronsson E

Biodistribution and dosimetry of 177Lu-labelled [DOTA0,Tyr3]octreotate in male nude mice with human small cell lung cancer.
Cancer Biotherapy and Radiopharmaceuticals, 18(4): 593-599, 2003.

Turesson I, Carlsson J, Brahme A, Glimelius B, Zackrisson B, Stenerlöw B, and the Swedish Cancer Society Investigation Group (including Forssell-Aronsson E and Johansson KA)

Biological response to radiation therapy.
Acta Oncol 42: 92-106, 2003.

Turesson I, Johansson KA, Mattsson S, and the Swedish Cancer Society Investigation Group (including Forssell-Aronsson E)

The potential of proton and light ion beams in radiotherapy.
Acta Oncol 42: 107-114, 2003.

Zackrisson B, Mattsson S, Kjellén E, Glimelius B, and the Swedish Cancer Society Investigation Group (including Forssell-Aronsson E and Johansson KA)

Research and development of radiation therapy in clinical routines.
Acta Oncol 42: 115-122, 2003.


Avdelningen för Radiofysik

Gula stråket 2B, Sahlgrenska Universitetssjukhuset, 413 45, Göteborg

Radiofysikhuset, Sahlgrenska Universitetssjukhuset

Sidansvarig: Johan Spetz|Sidan uppdaterades: 2013-01-07

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?